Exact Sciences and Pfizer extend agreement

Exact Sciences Corp. and Pfizer Inc. announced an extension of and amendment to their agreement to promote the at-home cancer test Cologuard.

Under the terms of the nationwide agreement, Pfizer will continue to provide marketing and related support for Cologuard and join Exact Sciences’ efforts to educate patients, physicians, and health systems about Cologuard. In the two years since the partnership began, more than 3 million people have been screened with Cologuard.